Skip to main content

An Ounce of Prevention

Now that the thirty-one days of Pinktober have passed, I feel safe enough to vent a bit of frustration with the whole breast cancer awareness movement. 

Don’t get me wrong—I recognize that fund-raising is a necessary underpinning of medical research, and I appreciate societal commitments to eradicating disease. It’s just that I’m not sure there’s anyone in America who is unaware of breast cancer, and it seems that more and more companies are skipping the altruism part and going pink strictly for profit.

Despite the tidal wave of pinktastic merchandise that floods October to amp up awareness, breast cancer continues to be diagnosed and, more disturbingly, to claim lives. 

Current research suggests that the emphasis on early detection has backfired, leading many women through unnecessary treatments for cancers that were never going to become invasive. However, the body of medicine remains confounded on how to predict and prevent metastatic breast cancer.

Even with the latest advances in treatment options, doctors are still unable to predict with certainty which of their patients will achieve long-term survival and which will suffer metastatic recurrence. A radiologist once summed it up to me this way: Breast cancer is sneaky.   

I hate to be a skeptic, but cancer is big business. From medical imaging to genetic testing, from cutting-edge surgical techniques to comprehensive oncology clinics, the quest for an ever-elusive “cure” is a money-maker that keeps medical industries booming.

I'm not sure there's a drug company out there that's truly interested in finding a cure. Drug companies are financially motivated to find marketable treatments for cancer, but curing it? That would be a fiscal disaster. 

Frankly, I'd rather see cancer stopped before it starts. I'd like for my daughter to grow up without worrying about whether or not she'll get breast cancer. Maybe instead of going down the rabbit hole in search of a cure, research should be focused on ferreting out and proving methods of prevention.

It's widely known that a variety of environmental influences can alter DNA, resulting in the development of cancer even in the absence of a genetic tendency. The standard American diet has been implicated as an emerging risk factor for breast and other cancers. Long on shelf life and short on nutrients, it packs a potent punch of endocrine-disruptive chemicals that wreak havoc in the body.

Every day, we ingest an astounding dose of estrogen-mimicking chemicals, unnecessary antibiotics, and extraneous hormones through the very foods they eat. Milk and meat from cows treated with bovine growth hormones. Soup from cans laced with BPA. Fruits and vegetables sprayed with pesticides and wax.

Sugar, a favorite additive of the food industry, has long been known to feed cancer cells. High fructose corn syrup, a staple ingredient on packaged food labels, is frequently sourced from genetically modified corn, which has been linked to increased rates of cancer in rats.

If the foods consumed by Americans activate cancer, doesn’t it stand to reason that changes in dietary practices could short circuit it completely? Wouldn’t it be prudent to thoroughly investigate this angle, to invest in research that harnesses the power of the fuel we put into our bodies to fight this illness?

I’m tired of pink ribbons and awareness and pinning a future on hope. I’m tired of hearing about the latest treatment options, each with its own set of debilitating side effects. I’m tired of fund-raising for a cure.  

It’s time to stop putting business before health. It’s time to reassess our priorities, to focus our efforts on mitigating the environmental factors that promote the proliferation of cellular changes that create cancer.

The proverbial ounce of prevention is worth a pound of cure.

Popular posts from this blog

My Love-Hate Relationship with Teaching

I have a confession to make, one that seemingly meets the criteria of a mundane mid-life crisis: I love what I do, but I hate my job. I’m a kindergarten teacher by trade. I adore children—always have, always will—and have a natural affinity for the littlest learners. I enjoy watching their growth across a school year, the way they come in green and fresh as newly planted seeds at the start, and leave my classroom as saplings stretching toward the infinite sky of knowledge and understanding. I hate the metrics that are used to define my students’ performance (and my own). I loathe the over-reliance on a narrow band of assessment measures that ignores the intangibles of student growth and extinguishes the joy of learning. I resent seeing children reduced to numbers on a grid in the name of data-based decision-making. I cherish the time I spend with my students in the Zone of Proximal Development. I thrive on the everyday teachable moments that enable me to coach into my stud...

Happy Cancerversary

Race for the Cure 2010, one month post-chemo. Yesterday marked six years from the day that I received the call telling me that the pathology report from my surgery four days earlier was in, and confirmed that I had cancer…for the second time. It was late in the day, as afternoon gave way to evening, its subtle waning light foreshadowing sunset. I remember marveling at the idea that my surgeon was still at work, reviewing reports and delivering verdicts, at such an hour.  It was spring break for me. I'd scheduled the surgery on the Monday after Easter so that I wouldn't have to take time off for it and, when the call came, I had just returned home from a run which, in hindsight, was either evidence of extremely poor judgment or the strength of my ability to ignore and deny the facts. I sat on the porch, cordless phone to my ear, furiously scribbling notes as I absorbed the news. It didn’t pack the same shock value as the first time I’d received this diagnosis, m...

Going Solo

I miss my right breast. There, I said it. It’s not often that I allow myself that luxury. It’s been nearly twelve years since I had it. My late breast was warm and soft, lovely really, even if it was a shave smaller than its mate, and parting with it saddened me deeply. I could say that I lost my breast, but that would imply that there was some remote possibility of getting it back. It’s more accurate to say that I removed it for medical reasons, and replaced it for cosmetic ones. If I had known how much the laborious process of reconstruction would hurt, I would have taken a pass on the effort. When the plastic surgeon explained the process of stretching that would precede placement of the actual implant, it did not occur to me that post-surgical skin might rebel against this strain on its capacity. However, once you’ve committed to the risk, you need to see it through to the reward, which is exactly what I did. I tolerated the pain for the eventual trophy—a cohesive sili...